Caladrius Biosciences, Inc. (LSTA) Tops Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts LSTA Hot Sheet
Join SI Premium – FREE
Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q2 EPS of ($0.61), $0.14 better than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
- CalPrivate Bank names Andra Frazier as chief credit officer
- Jefferies Starts Tamarack Valley Energy Ltd. (TVE:CN) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
